Nexentis Technologies Inc. Common Stock (NXTS)
Publicly reported company facts and saved market data for Nexentis Technologies Inc. Common Stock (NXTS), with sources and as-of times. Saved data is not a live quote.
Company profile
Nexentis Technologies Inc. (NASDAQ: NXTS) owns 100% of MitoCareX Bio Ltd, a drug discovery company. Additionally, Nexentis adopted an investment strategy focused on European renewable energy assets utilizing a RTB (Ready to Build) business model. The Company is currently the lead investor in four solar projects across three European Union countries, all introduced by Solterra Renewable Energy Ltd., a wholly owned subsidiary of Solterra Energy Ltd.
Company facts
- Sector
- Industrials
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.0M
- Incorporated in
- United States
- Company website
- www.n2off.com
- Exchange
- NASDAQ
Saved quote
Saved snapshot, not a real-time quote. Check the market time before relying on it.
- Last reported price
- $0.6212
- Reported change
- -11.74%
- Reported volume
- 91,859
- Latest market time
Short interest
- Reported short interest
- 39,461 shares
- Settlement date
- Source
- Nasdaq
Exchange-published short interest for the stated settlement date, not a live short position.
Recent daily sessions
The 10 most recent saved daily sessions, through . Daily OHLC and volume; not real-time.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 1.12 | 1.19 | 0.94 | 1.08 | 18,422,220 | |
| 1.39 | 1.41 | 1.38 | 1.39 | 3,220 | |
| 1.46 | 1.47 | 1.37 | 1.38 | 3,633 | |
| 1.44 | 1.50 | 1.41 | 1.49 | 5,276 | |
| 1.41 | 1.46 | 1.41 | 1.43 | 7,206 | |
| 1.33 | 1.43 | 1.33 | 1.39 | 10,914 | |
| 1.45 | 1.45 | 1.37 | 1.40 | 7,508 | |
| 1.45 | 1.50 | 1.45 | 1.47 | 6,842 | |
| 1.45 | 1.52 | 1.37 | 1.47 | 25,747 | |
| 1.52 | 1.55 | 1.31 | 1.46 | 74,342 |
Research this company
FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.
Sign in to continue